Relispray Antifungal Powder
Product Images NDC 46063-552

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Relispray Antifungal Powder (NDC 46063-552). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Midas-care Pharmaceuticals Pvt. Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (128 g Can Label)

Principal Display Panel (128 g Can Label)
This is a drug in the form of a spray powder that contains Miconazole nitrate 2%, which is used as an antifungal to effectively treat most types of athlete's foot, jock itch, and ringworm. The drug relieves itching, scaling, burning, and discomfort. The directions state to wash the affected area and dry it thoroughly, shake the can well and apply a layer twice daily (morning and evening), supervise children, pay special attention to spaces between the toes, wear well-ventilated shoes, and change shoes and socks at least once daily for at least 4 weeks. The drug should not be used on children under 2 years old, and the contents are flammable and should not be used while smoking or near flame. If there is no improvement within 4 weeks, stop using and consult a doctor. If swallowed, seek medical help or contact a Poison Control Center right away. This product is made in India by Midascare Pharmaceuticals Pvt. Ltd.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.